부비강암 시장 : 시장 규모, 점유율, 성장 분석 - 진단법별, 암 스테이지별, 치료법별, 최종 사용자별, 지역별 산업 예측(2025-2032년)
Paranasal Sinus Cancer Market Size, Share, and Growth Analysis, By Diagnosis (Medical history and physical examination, Imaging tests), By Stage of Cancer (Advanced, Localized), By Treatment, By End User, By Region - Industry Forecast 2025-2032
상품코드:1758615
리서치사:SkyQuest
발행일:2025년 06월
페이지 정보:영문 199 Pages
라이선스 & 가격 (부가세 별도)
한글목차
세계의 부비강암 시장 규모는 2023년에 19억 달러로 평가되었고, 2024년 20억 2,000만 달러에서 2032년에는 33억 2,000만 달러로 성장할 전망이며, 예측 기간인 2025-2032년 CAGR 6.4%로 성장할 것으로 예측됩니다.
세계의 부비강암 시장은 두경부암 환자 증가, 진단 및 생검 기술의 진보, 치료 옵션의 강화, 의료 부문의 의식 향상 등을 배경으로 큰 성장을 이루고 있습니다. 정부와 의료기관은 시장 확대를 지원하기 위해 인지도 향상, 연구 개발에 대한 자금 제공, 효과적인 공공 정책 제정, 엄격한 규제 실시 등을 적극적으로 추진하고 있습니다. 업계, 특히 인공지능의 혁신은 진단학에 변화를 가져오고, AI는 암의 조기 발견을 위한 MRI와 CT 스캔의 정밀도를 향상시키고 있습니다. 머신러닝 알고리즘은 치료를 개별화하기 위한 임상 데이터 분석에 사용됩니다. 또한 AI와 블록체인을 통합한 원격 의료 플랫폼의 이용이 확대됨에 따라 원격 진단이 용이해지고 진단 오류가 줄어 환자에 맞는 치료에 기여하고 있습니다.
목차
서문
분석 목적
시장 범위
정의
분석 기법
정보 조달
2차 및 1차 데이터의 수법
시장 규모 예측
시장의 상정 및 제약
주요 요약
시장 개요 및 전망
수급 동향의 분석
부문별 기회 분석
시장 역학 및 전망
시장 개요
시장 규모
시장 역학
성장 촉진요인 및 기회
성장 억제요인 및 과제
Porter's Five Forces 분석
주요 시장 인사이트
주요 성공 요인
경쟁도
주요 투자 기회
시장 생태계
시장 매력도 지수(2024년)
PESTEL 분석
거시경제지표
밸류체인 분석
가격 분석
세계의 부비강암 시장 규모 및 CAGR : 진단법별(2025-2032년)
시장 개요
병력 및 신체검사
화상 검사
X선
CT(컴퓨터 단층 촬영) 스캔
MRI(자기 공명 화상) 스캔
PET(양전자 방출 단층 촬영) 스캔
생검
세침 흡인 생검(FNA)
절개 생검 및 절제 생검
기타
세계의 부비강암 시장 규모 및 CAGR : 암 스테이지별(2025-2032년)
시장 개요
진행
국소
재발
세계의 부비강암 시장 규모 및 CAGR : 치료법별(2025-2032년)
시장 개요
수술
방사선요법
화학요법
세계의 부비강암 시장 규모 및 CAGR : 최종 사용자별(2025-2032년)
시장 개요
병원 및 클리닉
암치료 및 연구센터
연구실
기타
세계의 부비강암 시장 규모 및 CAGR(2025-2032년)
북미
미국
캐나다
유럽
독일
스페인
프랑스
영국
이탈리아
기타 유럽
아시아태평양
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카
브라질
기타 라틴아메리카
중동 및 아프리카
GCC 국가
남아프리카
기타 중동 및 아프리카
경쟁 구도
상위 5개사 비교
주요 기업의 시장 포지셔닝(2024년)
주요 기업이 채용한 전략
시장의 최근 동향
주요 기업의 시장 점유율(2024년)
주요 기업 프로파일
기업 개요
제품 포트폴리오 분석
부문별 점유율 분석
수익의 전년대비 비교(2022-2024년)
주요 기업 프로파일
F. Hoffmann-La Roche AG(Switzerland)
Bristol Myers Squibb(United States)
Merck & Co., Inc.(United States)
Pfizer Inc.(United States)
Eli Lilly and Company(United States)
AstraZeneca plc(United Kingdom)
Novartis AG(Switzerland)
Sanofi SA(France)
Johnson & Johnson(United States)
Bayer AG(Germany)
Exelixis, Inc.(United States)
Ipsen Biopharmaceuticals Inc.(France)
GlaxoSmithKline plc(GSK)(United Kingdom)
AbbVie Inc.(USA)
Kura Oncology, Inc.(USA)
Nanobiotix SA(France)
Teva Pharmaceutical Industries Ltd.(Israel)
Takeda Pharmaceutical Company Limited(Japan)
Mayo Clinic(United States)
MD Anderson Cancer Center(United States)
결론 및 권고
AJY
영문 목차
영문목차
Global Paranasal Sinus Cancer Market size was valued at USD 1.9 billion in 2023 and is poised to grow from USD 2.02 billion in 2024 to USD 3.32 billion by 2032, growing at a CAGR of 6.4% during the forecast period (2025-2032).
The global paranasal sinus cancer market is experiencing significant growth, driven by a rise in head and neck cancer cases, advancements in diagnostic and biopsy technologies, enhanced treatment options, and increased health sector awareness. Government and health organizations are actively promoting awareness, funding R&D, enacting effective public policies, and implementing strict regulations to support market expansion. Innovations in the industry, particularly in artificial intelligence, are transforming diagnostics, with AI improving MRI and CT scan accuracy for early cancer detection. Machine learning algorithms are being employed to analyze clinical data to personalize treatments. Additionally, the growing use of telemedicine platforms, incorporating AI and blockchain, facilitates remote consultations, reducing diagnostic errors and contributing to tailored patient care.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Paranasal Sinus Cancer market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Paranasal Sinus Cancer Market Segments Analysis
Global Paranasal Sinus Cancer Market is segmented by Diagnosis, Stage of Cancer, Treatment, End User and region. Based on Diagnosis, the market is segmented into Medical history and physical examination, Imaging tests, Biopsy and Others. Based on Stage of Cancer, the market is segmented into Advanced, Localized and Recurrent. Based on Treatment, the market is segmented into Surgery, Radiotherapy and Chemotherapy. Based on End User, the market is segmented into Hospital & Clinics, Cancer Treatment & Research Center, Research Laboratories and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Paranasal Sinus Cancer Market
The global paranasal sinus cancer market is witnessing significant transformation, largely driven by the increasing prevalence of tobacco consumption, which irritates and inflames the nasal cavity and heightens the risk of developing paranasal sinus cancer. This surge in cases necessitates sophisticated treatment options and diagnostic methods, including nasal endoscopy, CT scans, and MRI scans. As a result, there is a growing demand for products and services related to the diagnosis and treatment of paranasal sinus cancer. Consequently, the market is expanding rapidly, reflecting the urgent need for advanced healthcare solutions to address this serious condition.
Restraints in the Global Paranasal Sinus Cancer Market
The global market for paranasal sinus cancer faces significant restraints primarily due to its rarity and lack of public awareness. This limited recognition contributes to delays in diagnosis and insufficient medical support for patients. Furthermore, the infrequent nature of the disease diminishes the willingness of both governmental bodies and pharmaceutical companies to invest in research and development for effective treatments. Consequently, this translates into a slower progression in therapeutic advancements and awareness campaigns, ultimately hindering the growth of the paranasal sinus cancer market and leaving patients with fewer options for care and support.
Market Trends of the Global Paranasal Sinus Cancer Market
The Global Paranasal Sinus Cancer market is witnessing significant growth fueled by advancements in technology. Innovations such as liquid biopsies and next-generation sequencing are enhancing the detection and monitoring of early symptoms, allowing for timely intervention. Furthermore, the integration of artificial intelligence into diagnostic imaging, such as MRI and CT scans, is revolutionizing treatment protocols by providing personalized analyses of patient medical histories and responses to therapies. These technological advancements not only facilitate accurate diagnosis but also improve treatment outcomes, driving the demand for sophisticated healthcare solutions within the paranasal sinus cancer market. As technology evolves, continued growth is anticipated in this sector.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Drivers & Opportunities
Restraints & Challenges
Porters Analysis
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Global Paranasal Sinus Cancer Market Size by Diagnosis & CAGR (2025-2032)
Market Overview
Medical history and physical examination
Imaging tests
X-rays
CT (computed tomography) scan
MRI (magnetic resonance imaging) scan
PET (positron emission tomography) scan
Biopsy
Fine needle aspiration (FNA) biopsy
Incisional and excisional biopsies
Others
Global Paranasal Sinus Cancer Market Size by Stage of Cancer & CAGR (2025-2032)
Market Overview
Advanced
Localized
Recurrent
Global Paranasal Sinus Cancer Market Size by Treatment & CAGR (2025-2032)
Market Overview
Surgery
Radiotherapy
Chemotherapy
Global Paranasal Sinus Cancer Market Size by End User & CAGR (2025-2032)
Market Overview
Hospital & Clinics
Cancer Treatment & Research Center
Research Laboratories
Others
Global Paranasal Sinus Cancer Market Size & CAGR (2025-2032)
North America (Diagnosis, Stage of Cancer, Treatment, End User)
US
Canada
Europe (Diagnosis, Stage of Cancer, Treatment, End User)
Germany
Spain
France
UK
Italy
Rest of Europe
Asia Pacific (Diagnosis, Stage of Cancer, Treatment, End User)
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America (Diagnosis, Stage of Cancer, Treatment, End User)
Brazil
Rest of Latin America
Middle East & Africa (Diagnosis, Stage of Cancer, Treatment, End User)
